share_log

Can-Fite BioPharma Designated Orphan Designation Status For Namodenoson For The Treatment Of Pancreatic Cancer

Benzinga ·  Oct 8 22:14
Can-Fite BioPharma Designated Orphan Designation Status For Namodenoson For The Treatment Of Pancreatic Cancer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment